Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butantan Dengue Vaccine in Adults and Older Adults
NCT06891950Phase 3Recruiting
- Sponsor
- Instituto Butantan
- Start
- Mar 2026
- Primary completion
- Mar 2027
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of Butantan-DV in dengue fever, sponsored by Instituto Butantan. Started Mar 2026; status: recruiting.
02
Drugs
Butantan-DV
03
Conditions
dengue fever
Beyond the preview
Go deeper on NCT06891950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06891950.